NFKB1 and cancer: Considering TLR3 signaling and its downstream modulators have the capacity to amplify known hallmarks of cancer through mechanisms such as NF-κB activation, DNA damage via reactive species, enhanced transcription of genes promoting invasion and angiogenesis, and the generation of a pro-inflammatory microenvironment, its role in tumorigenesis cannot be overlooked.